Chronos Archive seal
The Human Record

Lou Gehrig

Case HR-ET018-TD · Modern EHR teaching episode · Draft for review

Review summary

Historical dates
June 19, 1903 – June 2, 1941
Synthetic DOB
1903-06-19
Index visit
1939-05-04 at age 35
Synthetic MRN
HR-ET018-SYN-TD

Teaching objective: Primary care for a 35-year-old professional baseball player with a year of progressive weakness and loss of coordination: recognizing mixed upper and lower motor neuron signs, excluding mimics (MRI of the brain and cervical spine, blood tests, EMG and nerve conduction studies), and making the diagnosis of amyotrophic lateral sclerosis on the Gold Coast and revised El Escorial criteria; riluzole with liver test monitoring, genetic testing (tofersen only for an SOD1 variant) and edaravone discussed; a multidisciplinary ALS clinic tracking ALSFRS-R, forced vital capacity and weight; nutrition, speech and swallowing, mobility equipment, noninvasive ventilation thresholds, work accommodation, mood screening, and early advance care planning, on the AAN ALS practice parameters (1922).

Historical timeline

DateEventClaims
June 19, 1903Born in Yorkville, Manhattan.CLM-0001
Winter of 1906Death of his sister Sophie.CLM-0002
February 1921Enrolled at Columbia University.CLM-0003
1938First neurological symptoms; batting average fell to .295.CLM-0005, CLM-0011
May 2, 1939Took himself out of the lineup after 2,130 consecutive games.CLM-0004
June 19, 1939Diagnosis of amyotrophic lateral sclerosis certified at the Mayo Clinic.CLM-0006
July 4, 1939Retired from baseball on Lou Gehrig Appreciation Day.CLM-0007
October 1939Accepted appointment as a New York City Parole Commissioner.CLM-0008
June 2, 1941Died at home in the Bronx.CLM-0009
June 17, 2016Published discussion of the head-trauma hypothesis and the sealed records.CLM-0010

Evidence claims

D = documented, R = retrospective, S = synthetic.

GradeClaimCertaintySources
D Henry Louis Gehrig was born on June 19, 1903, in the Yorkville section of Manhattan, New York, to Heinrich and Christina Gehrig, German immigrants.
The birth date used for the synthetic date of birth.
confirmed Ray JL. Lou Gehrig supports
D Three of his siblings died young: his sister Anna in September 1902 at about three months, his sister Sophie in the winter of 1906 of a combination of measles, diphtheria and bronchopneumonia, and a brother shortly after birth.
Family history; the causes of Anna's and the infant brother's deaths are not recorded in the cited source.
confirmed Ray JL. Lou Gehrig supports
D He enrolled at Columbia University on a football scholarship in February 1921.
Social history.
confirmed Ray JL. Lou Gehrig supports
D He played first base for the New York Yankees and, on May 2, 1939, in Detroit, took himself out of the lineup after a then-record 2,130 consecutive games.
The anchor for the index date. PBS gives May 1, 1939; the Hall of Fame and SABR accounts of Detroit on May 2 are used.
confirmed Gehrig, Hunter and Frates each furthered cause of ALS cure supports
Hall of Fame opened the day of Lou Gehrig's final game supports
Markel H. Did Lou Gehrig actually die of Lou Gehrig's disease? supports
D In 1938 he batted .295, the first time under .300 since 1925, and his hitting fell off sharply in midsummer; he had an attack of lumbago and a badly jammed thumb that season. In the winter of 1938 to 1939 he lost his strength and collapsed while ice skating, in spring training 1939 he collapsed while putting on his uniform pants and his reflexes had slowed alarmingly, and at 35 he batted .143 in the first games of the 1939 season.
The anchor for the modern presenting problem: a year of progressive weakness and loss of coordination.
confirmed Ray JL. Lou Gehrig supports
Gehrig, Hunter and Frates each furthered cause of ALS cure supports
Hall of Fame opened the day of Lou Gehrig's final game supports
D His first neurological symptoms began in 1938, around the time of his 35th birthday.
The anchor for the onset of weakness in the modern episode.
probable Markel H. Did Lou Gehrig actually die of Lou Gehrig's disease? supports
D He had repeated head injuries, including concussions, during his playing career.
Recorded as history; the modern episode records a history of concussions without assuming any effect.
probable Markel H. Did Lou Gehrig actually die of Lou Gehrig's disease? supports
D He was examined at the Mayo Clinic in Rochester, Minnesota, from June 13 to June 19, 1939, and on his 36th birthday his internist, Harold C. Habein, certified the diagnosis of amyotrophic lateral sclerosis; the clinic's statement added that he could continue in some executive activity.
The anchor for the modern diagnosis; after the true-frame index date. The Hall of Fame spells the physician's name Hobein in one article.
confirmed Markel H. Did Lou Gehrig actually die of Lou Gehrig's disease? supports
Gehrig, Hunter and Frates each furthered cause of ALS cure supports
Ray JL. Lou Gehrig supports
D He retired from baseball on July 4, 1939, when the Yankees held Lou Gehrig Appreciation Day before nearly 42,000 fans; in his speech he said that he considered himself "the luckiest man on the face of the earth."
History only; after the true-frame index date.
confirmed Ray JL. Lou Gehrig supports
Gehrig, Hunter and Frates each furthered cause of ALS cure supports
Hall of Fame opened the day of Lou Gehrig's final game supports
D In October 1939 he accepted Mayor La Guardia's appointment to a ten-year term as a New York City Parole Commissioner, was sworn in on January 2, 1940, and resigned quietly about a month before his death because his condition made the work impossible.
The anchor for the modern work-accommodation theme (a desk role in public service); after the true-frame index date.
confirmed Ray JL. Lou Gehrig supports
D He died at his home on Delafield Avenue in the Fieldston section of the Bronx on June 2, 1941, at 37.
History only. PBS gives June 3, 1941.
confirmed Ray JL. Lou Gehrig supports
Gehrig, Hunter and Frates each furthered cause of ALS cure supports
Markel H. Did Lou Gehrig actually die of Lou Gehrig's disease? disputes
R Researchers at the Boston University center for the study of traumatic encephalopathy have suggested that repetitive head trauma can cause a syndrome that mimics ALS, and that his repeated head injuries may have contributed to his decline; the Mayo Clinic has sealed his records, and it is not known whether an autopsy was performed.
A retrospective hypothesis; the documented diagnosis remains ALS and the modern episode does not adopt the hypothesis.
disputed Markel H. Did Lou Gehrig actually die of Lou Gehrig's disease? supports

Modern synthetic problem list

GradeProblemClinical statusVerificationPlacementHistorical claims
S Progressive weakness and loss of coordination for about a year: fumbling with buttons and a bat, tripping on curbs, a fall on the ice in the winter, muscle cramps and twitching in the arms and thighs; no numbness, pain, double vision, or trouble speaking or swallowing. Examination: wasting of the hand muscles (left more than right), fasciculations in both arms and thighs, weakness of grip and of left ankle dorsiflexion, brisk reflexes with spread and a positive Hoffmann sign, normal sensation. Mixed upper and lower motor neuron signs; evaluation for motor neuron disease and its mimics begun, with neuromuscular neurology consultation booked resolved confirmed active CLM-0004, CLM-0005, CLM-0011
S Amyotrophic lateral sclerosis, limb onset: progressive weakness for about a year with upper and lower motor neuron signs in the cervical and lumbosacral regions, and active and chronic denervation on EMG in the cervical, thoracic and lumbosacral regions with normal sensory nerve conduction; MRI of the brain and cervical spine and blood tests exclude mimics. Meets the Gold Coast criteria and the revised El Escorial category of clinically probable ALS. ALSFRS-R 42 and FVC 88% of predicted at diagnosis. Synthetic modern episode linked to his documented diagnosis active confirmed both_with_link CLM-0006, CLM-0011
S Sprain of the left lateral ankle ligaments after tripping on a curb with left foot drop, while not wearing his ankle-foot orthosis: swelling and tenderness over the anterior talofibular ligament, able to bear weight, no bony tenderness by the Ottawa ankle rules; resolved resolved confirmed active

Synthetic outcome measures

GradeDateMeasureResultCoding
S 1939-05-04 Leukocytes [#/volume] in Blood by Automated count 6.8 10*3/uL
Reference 4-11 10*3/uL
http://loinc.org · 6690-2
S 1939-05-04 Hemoglobin [Mass/volume] in Blood 15.2 g/dL
Reference 13.2-17.1 g/dL
http://loinc.org · 718-7
S 1939-05-04 Platelets [#/volume] in Blood by Automated count 245 10*3/uL
Reference 150-400 10*3/uL
http://loinc.org · 777-3
S 1939-05-04 Sodium [Moles/volume] in Serum or Plasma 140 mmol/L
Reference 135-145 mmol/L
http://loinc.org · 2951-2
S 1939-05-04 Potassium [Moles/volume] in Serum or Plasma 4.4 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 1939-05-04 Creatinine [Mass/volume] in Serum or Plasma 0.88 mg/dL
Reference 0.74-1.35 mg/dL
http://loinc.org · 2160-0
S 1939-05-04 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1934)/1.73 sq M 115 mL/min/1.73 m²
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 1939-05-04 Glucose [Mass/volume] in Serum or Plasma 92 mg/dL
Reference 70-99 mg/dL
http://loinc.org · 2345-7
S 1939-05-04 Calcium [Mass/volume] in Serum or Plasma 9.4 mg/dL
Reference 8.6-10.3 mg/dL
http://loinc.org · 17861-6
S 1939-05-04 Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 32 U/L
Reference 7-55 U/L
http://loinc.org · 1742-6
S 1939-05-04 Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 30 U/L
Reference 10-40 U/L
http://loinc.org · 1920-8
S 1939-05-04 Creatine kinase [Enzymatic activity/volume] in Serum or Plasma 412 U/L (high)
Reference 39-308 U/L
http://loinc.org · 2157-6
S 1939-05-04 Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma 512 pg/mL
Reference 232-1245 pg/mL
http://loinc.org · 2132-9
S 1939-05-04 Thyrotropin [Units/volume] in Serum or Plasma 1.6 mIU/L
Reference 0.45-4.5 mIU/L
http://loinc.org · 3016-3
S 1939-05-04 Hemoglobin A1c/Hemoglobin.total in Blood 5.2%
Reference Below 5.7% is normal; 5.7 to 6.4% prediabetes
http://loinc.org · 4548-4
S 1939-05-04 Forced vital capacity [Volume] Respiratory system 4.62 L
Reference >=4.1 L
http://loinc.org · 19870-5
S 1939-05-04 FVC measured/predicted 90%
Reference 80% of predicted or more is normal; noninvasive ventilation is considered below 50%
http://loinc.org · 19872-1
S 1939-05-04 Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 1 http://loinc.org · 55758-7
S 1939-05-18 Forced vital capacity [Volume] Respiratory system 4.52 L
Reference >=4.1 L
http://loinc.org · 19870-5
S 1939-05-18 FVC measured/predicted 88%
Reference 80% of predicted or more is normal; noninvasive ventilation is considered below 50%
http://loinc.org · 19872-1
S 1939-05-18 Total score [ALSFRS-R] 42 http://loinc.org · 82953-1
S 1939-05-18 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 7 http://loinc.org · 44261-6
S 1939-06-29 Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 38 U/L
Reference 7-55 U/L
http://loinc.org · 1742-6
S 1939-06-29 Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 33 U/L
Reference 10-40 U/L
http://loinc.org · 1920-8
S 1939-06-29 Forced vital capacity [Volume] Respiratory system 4.31 L
Reference >=4.1 L
http://loinc.org · 19870-5
S 1939-06-29 FVC measured/predicted 84%
Reference 80% of predicted or more is normal; noninvasive ventilation is considered below 50%
http://loinc.org · 19872-1
S 1939-06-29 Total score [ALSFRS-R] 40 http://loinc.org · 82953-1
S 1939-06-29 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 8 http://loinc.org · 44261-6
S 1939-08-24 Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 35 U/L
Reference 7-55 U/L
http://loinc.org · 1742-6
S 1939-08-24 Forced vital capacity [Volume] Respiratory system 4.05 L (low)
Reference >=4.1 L
http://loinc.org · 19870-5
S 1939-08-24 FVC measured/predicted 79% (low)
Reference 80% of predicted or more is normal; noninvasive ventilation is considered below 50%
http://loinc.org · 19872-1
S 1939-08-24 Total score [ALSFRS-R] 38 http://loinc.org · 82953-1
S 1939-08-24 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 7 http://loinc.org · 44261-6
S 1939-10-19 Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 33 U/L
Reference 7-55 U/L
http://loinc.org · 1742-6
S 1939-10-19 Forced vital capacity [Volume] Respiratory system 3.69 L (low)
Reference >=4.1 L
http://loinc.org · 19870-5
S 1939-10-19 FVC measured/predicted 72% (low)
Reference 80% of predicted or more is normal; noninvasive ventilation is considered below 50%
http://loinc.org · 19872-1
S 1939-10-19 Total score [ALSFRS-R] 36 http://loinc.org · 82953-1
S 1939-10-19 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 6 http://loinc.org · 44261-6
S 1939-07-20 Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 41 U/L
Reference 7-55 U/L
http://loinc.org · 1742-6
S 1939-09-21 Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 1 http://loinc.org · 55758-7
S 1939-09-21 Total score [AUDIT-C] 2 http://loinc.org · 75626-2

Synthetic vital signs

DateMeasureResultLOINCGrade
1939-05-04Body height183 cm8302-2S
1939-05-04Body weight89.5 kg29463-7S
1939-05-04Body mass index (BMI) [Ratio]26.7 kg/m239156-5S
1939-05-04Systolic blood pressure124 mm[Hg]8480-6S
1939-05-04Diastolic blood pressure78 mm[Hg]8462-4S
1939-05-04Heart rate68 /min8867-4S
1939-05-04Respiratory rate14 /min9279-1S
1939-05-04Body temperature36.7 Cel8310-5S
1939-05-04Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
1939-05-18Body height183 cm8302-2S
1939-05-18Body weight89.2 kg29463-7S
1939-05-18Body mass index (BMI) [Ratio]26.6 kg/m239156-5S
1939-05-18Systolic blood pressure122 mm[Hg]8480-6S
1939-05-18Diastolic blood pressure76 mm[Hg]8462-4S
1939-05-18Heart rate70 /min8867-4S
1939-05-18Respiratory rate14 /min9279-1S
1939-05-18Body temperature36.6 Cel8310-5S
1939-05-18Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
1939-06-29Body height183 cm8302-2S
1939-06-29Body weight88.4 kg29463-7S
1939-06-29Body mass index (BMI) [Ratio]26.4 kg/m239156-5S
1939-06-29Systolic blood pressure120 mm[Hg]8480-6S
1939-06-29Diastolic blood pressure76 mm[Hg]8462-4S
1939-06-29Heart rate72 /min8867-4S
1939-06-29Respiratory rate15 /min9279-1S
1939-06-29Body temperature36.7 Cel8310-5S
1939-06-29Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
1939-08-24Body height183 cm8302-2S
1939-08-24Body weight87.4 kg29463-7S
1939-08-24Body mass index (BMI) [Ratio]26.1 kg/m239156-5S
1939-08-24Systolic blood pressure118 mm[Hg]8480-6S
1939-08-24Diastolic blood pressure74 mm[Hg]8462-4S
1939-08-24Heart rate74 /min8867-4S
1939-08-24Respiratory rate16 /min9279-1S
1939-08-24Body temperature36.6 Cel8310-5S
1939-08-24Oxygen saturation in Arterial blood by Pulse oximetry97 %59408-5S
1939-10-19Body height183 cm8302-2S
1939-10-19Body weight86.6 kg29463-7S
1939-10-19Body mass index (BMI) [Ratio]25.9 kg/m239156-5S
1939-10-19Systolic blood pressure118 mm[Hg]8480-6S
1939-10-19Diastolic blood pressure74 mm[Hg]8462-4S
1939-10-19Heart rate76 /min8867-4S
1939-10-19Respiratory rate16 /min9279-1S
1939-10-19Body temperature36.6 Cel8310-5S
1939-10-19Oxygen saturation in Arterial blood by Pulse oximetry97 %59408-5S
1939-07-20Body height183 cm8302-2S
1939-07-20Body weight88 kg29463-7S
1939-07-20Body mass index (BMI) [Ratio]26.3 kg/m239156-5S
1939-07-20Systolic blood pressure122 mm[Hg]8480-6S
1939-07-20Diastolic blood pressure76 mm[Hg]8462-4S
1939-07-20Heart rate74 /min8867-4S
1939-07-20Respiratory rate15 /min9279-1S
1939-07-20Body temperature36.6 Cel8310-5S
1939-07-20Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
1939-09-21Body height183 cm8302-2S
1939-09-21Body weight87 kg29463-7S
1939-09-21Body mass index (BMI) [Ratio]26 kg/m239156-5S
1939-09-21Systolic blood pressure118 mm[Hg]8480-6S
1939-09-21Diastolic blood pressure74 mm[Hg]8462-4S
1939-09-21Heart rate74 /min8867-4S
1939-09-21Respiratory rate16 /min9279-1S
1939-09-21Body temperature36.6 Cel8310-5S
1939-09-21Oxygen saturation in Arterial blood by Pulse oximetry97 %59408-5S

Social, functional, and mental status

Social history

Functional status

Mental status

Allergies and medications

Allergies

Medications

Procedures and immunizations

Procedures

Immunizations

Past medical history

True biography with historical dates; not part of the synthetic care timeline.

Family history

Care-plan goals

GoalTarget dateStatusOutcome
A clear diagnosis, with mimics excluded, within four weeks1939-05-18completedDiagnosis made at two weeks on EMG, MRI and blood tests
No falls, using an ankle-foot orthosis, a cane, and a safer home1939-10-19activeOne fall with an ankle sprain in July, on a day the orthosis was not worn; no falls since it has been worn for all walking outdoors
Weight held within 5% of the weight at diagnosis1939-10-19completed89.2 kg at diagnosis and 86.6 kg at five months (2.9% lower)
Breathing tracked every visit, with noninvasive ventilation started as soon as criteria are met1939-10-19activeFVC 72% and no symptoms at five months; overnight oximetry ordered
Goals of care, a health care agent, and his wishes about ventilation and feeding recorded early and revisited1939-09-21completedAgent named and wishes recorded at the preventive visit
Working in a role that suits him, with accommodations1939-10-19completedStarted a desk role in public service with accommodations

Interventions

InterventionStatusGuideline
Evaluation of progressive weakness with mixed upper and lower motor neuron signs: blood count, metabolic panel with calcium, creatine kinase, vitamin B12, TSH, A1c, serum protein electrophoresis with immunofixation, and an HIV test; MRI of the brain and cervical spine; seated spirometrycompletedGL-GOLDCOAST-2020, GL-ELESCORIAL-2000, GL-AAN-ALS-CARE-2009
Neuromuscular neurology consultation with EMG and nerve conduction studies for progressive weakness with mixed upper and lower motor neuron signscompletedGL-GOLDCOAST-2020, GL-AAN-ALS-CARE-2009
Safety while the evaluation proceeds: no competitive play or heavy lifting, a physical therapy assessment of balance and gait, home fall precautions (night lights, rails, no loose rugs), and a same-day call for any trouble swallowing or breathing; results given to him first, in personcompletedGL-AAN-ALS-CARE-2009
Riluzole 50 mg twice daily, with ALT monthly for the first 3 months and then every 3 months, and a blood count with any fever; genetic testing with genetic counseling for ALS-associated genes, with tofersen only if an SOD1 variant is found; edaravone discussed as an option with modest evidence in a selected groupcompletedGL-AAN-ALS-DRUG-2009, GL-ALS-GENETICS-2023, GL-TOFERSEN-2022
Multidisciplinary ALS clinic every 2 to 3 months (neurology, nursing, physical, occupational and speech therapy, nutrition, respiratory therapy, social work and mental health): ALSFRS-R, seated forced vital capacity and maximal inspiratory pressure, and weight at every visit; cognitive and behavioral screening; PHQ-9completedGL-AAN-ALS-CARE-2009, GL-ALSFRSR-1999
Respiratory plan: forced vital capacity and maximal inspiratory pressure every visit, supine capacity and overnight oximetry when values fall or symptoms appear; noninvasive ventilation when forced vital capacity is below 50% of predicted, maximal inspiratory pressure is weaker than -60 cmH2O, overnight oximetry shows desaturation, or orthopnea or morning headaches appear; influenza and COVID-19 vaccinescompletedGL-AAN-ALS-DRUG-2009, GL-CDC-IMZ-2026
Nutrition, speech, swallowing and mobility: a high-calorie diet to keep weight stable, with gastrostomy discussed early, while forced vital capacity is above 50%; speech and swallowing assessments every visit and voice banking; a left ankle-foot orthosis, a cane, and an early power wheelchair evaluation because of lead times; home and car adaptationscompletedGL-AAN-ALS-DRUG-2009, GL-AAN-ALS-CARE-2009
Work and planning: workplace accommodations for a desk role (accessible office, flexible hours, rest breaks, voice-recognition software, parking), information on disability benefits, social work support, and early advance care planning, revisited at each changecompletedGL-AAN-ALS-CARE-2009

Planned encounters

Supporting documents

C-CDA note documents

Each link opens a readable copy; the XML beside it is the exchange file.

Sources

IDSourcePublisherType
SRC-0001 Ray JL. Lou Gehrig Society for American Baseball Research (SABR) BioProject biography
SRC-0002 Gehrig, Hunter and Frates each furthered cause of ALS cure National Baseball Hall of Fame and Museum biography
SRC-0003 Hall of Fame opened the day of Lou Gehrig's final game National Baseball Hall of Fame and Museum biography
SRC-0004 Markel H. Did Lou Gehrig actually die of Lou Gehrig's disease? PBS NewsHour other
SRC-0005 HISTMED Master Roster v3 The Human Record project other

Review status

ReviewStatusNotes
schema validationnot_startedRun scripts/build.ps1 -Conformance.
clinical reviewnot_startedAwaiting clinician review; check the mimic work-up, the EMG criteria (Gold Coast and revised El Escorial), riluzole liver monitoring, the decisions on edaravone and tofersen, the noninvasive ventilation thresholds, gastrostomy timing, and work accommodation.
provenance reviewnot_startedThe SABR biography (Ray), two National Baseball Hall of Fame articles, and PBS NewsHour (Markel 2016) logged. The death date conflict (June 2 or 3, 1941) and the head-trauma hypothesis (R, disputed) are recorded.
safe messaging reviewnot_startedA progressive fatal illness: the modern episode screens mood at every visit (PHQ-9 below 10 throughout) and plans care early; his documented speech is quoted only as history; no decision, statement or health fact is attributed to his wife or other real people.

Comments and corrections

Sign in with GitHub to comment on this record. To report a specific error, ideally with a source, use the feedback form; each report becomes a tracked issue.

Comments appear on the online version of this page.